Joint Working between Roche and the NHS
At Roche we firmly believe that better patient care can be achieved through Joint Working with the NHS. This is why we support and actively implement theDepartment of Health guidance on Joint Working
What is Joint Working?
Joint Working is defined in theDepartment of Health guidance on Joint Working as:
Situations where, for the benefit of patients, one or more pharmaceutical companies and the NHS pool skills, experience and/or resources for the joint development and implementation of patient centred projects and share a commitment to successful delivery
Roche has successfully worked and continues to work alongside national, regional, and local NHS organisations to support and implement developments in healthcare delivery for the benefits of patients
Our Joint Working projects to date have aimed to:
- Improve quality throughout a patient's healthcare pathway
- Implement alternative models of care to increase patient access to care
- Support redesign of disease management services
- Better use of data to measure healthcare outcomes and reduce inequalities
- Enable NHS spending to translate into better healthcare outcomes
- Share good clinical practice across the NHS
All of this we believe can lead to patient benefits – access to quality healthcare services, and better healthcare outcomes.
Roche UK has a number of roles that are able to deliver Joint Working Projects with the NHS. The value of these roles and the time spent on specific projects is not factored into any Transfer of Value disclosures.
Below is a list of Joint Working projects Roche is currently involved in. Click on the Executive Summary links below to learn more:
|Developing new contracting models and currencies for cancer medicines||August 2018||Roche Products Ltd and the Christie NHS Foundation Trust||(118KB)|
|Somerset Cancer Programme – Programme Management||July 2018||Roche Products Ltd, Yeovil District Hospital NHS Foundation Trust, Taunton & Somerset NHS Foundation Trust, Somerset Clinical Commissioning Group, Somerset Partnership NHS Foundation Trust.||(120KB)|
|Development of Quality Metrics in Multiple Sclerosis (MS)||November 2017||Blizard Institute, University of Plymouth, The Walton Centre NHS Foundation Trust, The Newcastle upon Tyne Hospitals NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust, St George’s University Hospitals NHS Foundation Trust, Revive MS, MS Society, MS Trust, The Healthcare Financial Management Association||(121KB)|
|Somerset Cancer Programme Lung Cancer Pathway Project (a Phase 2 project of the Somerset Cancer Programme Joint working project)||October 2017||Roche Products Ltd and NHS England South West Strategic Clinical Network, coordinating contributions from Yeovil NHS Foundation Trust(FT), NHS England South (South West), Taunton and Somerset NHS Foundation Trust(FT), Somerset Clinical Commissioning Group(CCG)||(228KB)|
|Oncology Pharmacy Medicines Optimisation||October 2017||Guy’s and St Thomas’ NHS Foundation Trust (GSST) and Roche Products Ltd.||(36.6KB)|
|Somerset Cancer Programme - Prioritisation Phase (a Phase 2 project of the Somerset Cancer Programme Joint working project)||September 2017||Roche Products Ltd and NHS England South West Strategic Clinical Network, coordinating contributions from Yeovil NHS Foundation Trust(FT), NHS England South (South West), Taunton and Somerset NHS Foundation Trust(FT), Somerset Clinical Commissioning Group(CCG)||(310KB)|
|Royal Marsden - Chemotherapy Closer to Home||July 2017||The Royal Marsden NHS Foundation Trust and Roche Products Ltd||(310KB)|
|Development of a costed pathway for early and advanced breast cancer and simulation model||May 2017||The Clatterbridge Cancer Center NHS Foundation Trust and Roche Products Ltd.||(228KB)|
|Sub-Regional Cancer Services Pharmacist to support implementation of the Carter Review||January 2017||County Durham and Darlington NHS Foundation Trust and Roche Products Ltd||(314KB)|
|NHS Tayside costed review of current and proposed service pathway for oncology subcut medicines.||December 2016||Tayside Health Board, The University of Dundee and Roche Products Ltd||(189KB)|
|Redesign of interstitial lung disease (ILD) service – proof of concept to inform ILD service development locally and regionally.||December 2016||The University Hospitals South Manchester NHS Foundation, Pennine Acute Hospitals Trust and Roche Products Ltd.||(226KB)|
|Proof of concept – a new model of care for Idiopathic Pulmonary Fibrosis (IPF) patients. Holistic approach to assessment via nurse consultant clinic.||October 2016||Royal Brompton and Harefield NHS Foundation Trust and Roche Products Ltd.||(291 KB)|
|Somerset Cancer Programme||September 2016||Roche Products Ltd and NHS England South West Strategic Clinical Network, coordinating contributions from Yeovil FT, NHS England South (South West), Taunton and Somerset FT, Somerset CCG||(33 KB)|
For further information on existing Joint Working projects or to explore Joint Working opportunities with Roche pleasecontact us.